Armistice Capital, Llc Del Frisco'S Restaurant Group, Inc. (DFRG) insider trading activity

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held N/A

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 25 2019	SELL Other acquisition or disposition	$49,000,000 $8.0 p/Share	6,125,000 Reduced 100.0%	0 Common Stock
Jun 04 2019	BUY Open market or private purchase	$149,000 $5.96 p/Share	25,000 Added 0.41%	6,125,000 Common Stock
May 16 2019	BUY Open market or private purchase	$318,500 $4.9 p/Share	65,000 Added 1.05%	6,100,000 Common Stock
May 14 2019	BUY Open market or private purchase	$184,450 $5.27 p/Share	35,000 Added 0.58%	6,035,000 Common Stock
May 10 2019	BUY Open market or private purchase	$319,550 $5.81 p/Share	55,000 Added 0.91%	6,000,000 Common Stock
May 09 2019	BUY Open market or private purchase	$329,450 $5.99 p/Share	55,000 Added 0.92%	5,945,000 Common Stock
May 08 2019	BUY Open market or private purchase	$173,400 $5.78 p/Share	30,000 Added 0.51%	5,890,000 Common Stock
May 07 2019	BUY Open market or private purchase	$679,800 $6.18 p/Share	110,000 Added 1.84%	5,860,000 Common Stock
Apr 30 2019	BUY Open market or private purchase	$464,800 $6.64 p/Share	70,000 Added 1.2%	5,750,000 Common Stock
Apr 25 2019	BUY Open market or private purchase	$201,900 $6.73 p/Share	30,000 Added 0.53%	5,680,000 Common Stock
Apr 03 2019	BUY Open market or private purchase	$319,500 $6.39 p/Share	50,000 Added 0.88%	5,650,000 Common Stock
Mar 27 2019	BUY Open market or private purchase	$63,500 $6.35 p/Share	10,000 Added 0.18%	5,600,000 Common Stock
Mar 26 2019	BUY Open market or private purchase	$256,800 $6.42 p/Share	40,000 Added 0.71%	5,590,000 Common Stock
Mar 25 2019	BUY Open market or private purchase	$320,000 $6.4 p/Share	50,000 Added 0.89%	5,550,000 Common Stock
Mar 21 2019	BUY Open market or private purchase	$644,000 $6.44 p/Share	100,000 Added 1.79%	5,500,000 Common Stock
Mar 20 2019	BUY Open market or private purchase	$951,000 $6.34 p/Share	150,000 Added 2.7%	5,400,000 Common Stock
Mar 18 2019	BUY Open market or private purchase	$816,340 $6.86 p/Share	119,000 Added 2.22%	5,250,000 Common Stock
Mar 15 2019	BUY Open market or private purchase	$2,323,620 $7.02 p/Share	331,000 Added 6.06%	5,131,000 Common Stock
Mar 14 2019	BUY Open market or private purchase	$723,000 $7.23 p/Share	100,000 Added 2.04%	4,800,000 Common Stock
Mar 13 2019	BUY Open market or private purchase	$395,000 $7.9 p/Share	50,000 Added 1.05%	4,700,000 Common Stock
Mar 12 2019	BUY Open market or private purchase	$400,500 $8.01 p/Share	50,000 Added 1.06%	4,650,000 Common Stock
Mar 06 2019	BUY Open market or private purchase	$246,300 $8.21 p/Share	30,000 Added 0.65%	4,600,000 Common Stock
Jan 29 2019	BUY Open market or private purchase	$44,845 $7.76 p/Share	5,779 Added 0.13%	4,570,000 Common Stock
Jan 28 2019	BUY Open market or private purchase	$19,235 $7.88 p/Share	2,441 Added 0.05%	4,564,221 Common Stock
Jan 25 2019	BUY Open market or private purchase	$268,213 $7.94 p/Share	33,780 Added 0.74%	4,561,780 Common Stock

Also insider at

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL